Cargando…

2571. Norovirus Infection and Gut Microbiota in Transplant Recipients

BACKGROUND: In vitro studies have shown that enteric viruses require the gut microbiota (specific members of the Enterobacteriaceae family) for efficient infection of the gastrointestinal tract. Human norovirus (NV) infection in transplant recipients may be chronic and severe. The role of gut microb...

Descripción completa

Detalles Bibliográficos
Autores principales: Chong, Pearlie P, Hussain, Sarah K, Poulides, Nicole, Coughlin, Laura, Koh, Andrew Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810383/
http://dx.doi.org/10.1093/ofid/ofz360.2249
_version_ 1783462240044711936
author Chong, Pearlie P
Chong, Pearlie P
Hussain, Sarah K
Poulides, Nicole
Coughlin, Laura
Koh, Andrew Y
author_facet Chong, Pearlie P
Chong, Pearlie P
Hussain, Sarah K
Poulides, Nicole
Coughlin, Laura
Koh, Andrew Y
author_sort Chong, Pearlie P
collection PubMed
description BACKGROUND: In vitro studies have shown that enteric viruses require the gut microbiota (specific members of the Enterobacteriaceae family) for efficient infection of the gastrointestinal tract. Human norovirus (NV) infection in transplant recipients may be chronic and severe. The role of gut microbiota has not been defined in this setting. We hypothesized that gut microbiota diversity and composition are different in norovirus-infected transplant patients. METHODS: We performed a single-center, pilot, prospective cohort study of adult solid-organ transplant and hematopoietic stem cell transplant recipients with diarrhea. Serial fecal samples were collected and processed for gDNA. Norovirus levels were quantified by PCR and gut microbiota profiling determined by 16S rRNA gene sequencing. RESULTS: Twenty-five transplant recipients were included: 9 with NV infection and 16 without. Age (61 ± SEM 2.3 years vs. 54 ± 3.5 years; P = 0.172), duration of diarrhea prior to diagnosis (105 ± 43 days vs. 20 ± 7 days; P = 0.146), prior cumulative antibiotic use (42 ± 12 days vs. 46 ± 17 days; P = 0.646), anti-anaerobic antibiotic use (7 ± 3 days vs. 11 ± 6 days; P = 0.643) and length of hospitalization (12 ± 6 days vs. 12 ± 3 days; P = 0.624) were not different between transplant recipients with and without NV infection. Interestingly, the relative abundance of Enterobactericeae was significantly higher in NV-infected transplant recipients compared with those without NV infection (26 ± 5.8% vs. 6.2 ± 2.8%; P = 0.017, Mann–Whitney) (Figure 1). In contrast, the abundance of the Phyla Bacteroidetes (11.2 ± 5.2% vs. 26.3 ± 6.5%; P = 0.191), and Firmicutes (26.8 ± 7.6% vs. 24.9 ± 4.7%; P = 0.803), were not significantly different between those who were NV and not NV-infected. Of note, the diversity metrics of Shannon (3.5 ± 0.4 vs. 3.8 ± 0.3; P = 0.637) and inverse Simpson indices (1.3 ± 0.1 vs. 1.1±0.1; P = 0.419) were not significantly different between the two groups. CONCLUSION: Norovirus-infected transplant recipients had a significantly higher relative abundance of Enterobactericeae in their gut microbiota compared with transplant recipients without norovirus infection. Future studies are needed to explore if this association is mechanistically important for norovirus infection. [Image: see text] DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6810383
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-68103832019-10-28 2571. Norovirus Infection and Gut Microbiota in Transplant Recipients Chong, Pearlie P Chong, Pearlie P Hussain, Sarah K Poulides, Nicole Coughlin, Laura Koh, Andrew Y Open Forum Infect Dis Abstracts BACKGROUND: In vitro studies have shown that enteric viruses require the gut microbiota (specific members of the Enterobacteriaceae family) for efficient infection of the gastrointestinal tract. Human norovirus (NV) infection in transplant recipients may be chronic and severe. The role of gut microbiota has not been defined in this setting. We hypothesized that gut microbiota diversity and composition are different in norovirus-infected transplant patients. METHODS: We performed a single-center, pilot, prospective cohort study of adult solid-organ transplant and hematopoietic stem cell transplant recipients with diarrhea. Serial fecal samples were collected and processed for gDNA. Norovirus levels were quantified by PCR and gut microbiota profiling determined by 16S rRNA gene sequencing. RESULTS: Twenty-five transplant recipients were included: 9 with NV infection and 16 without. Age (61 ± SEM 2.3 years vs. 54 ± 3.5 years; P = 0.172), duration of diarrhea prior to diagnosis (105 ± 43 days vs. 20 ± 7 days; P = 0.146), prior cumulative antibiotic use (42 ± 12 days vs. 46 ± 17 days; P = 0.646), anti-anaerobic antibiotic use (7 ± 3 days vs. 11 ± 6 days; P = 0.643) and length of hospitalization (12 ± 6 days vs. 12 ± 3 days; P = 0.624) were not different between transplant recipients with and without NV infection. Interestingly, the relative abundance of Enterobactericeae was significantly higher in NV-infected transplant recipients compared with those without NV infection (26 ± 5.8% vs. 6.2 ± 2.8%; P = 0.017, Mann–Whitney) (Figure 1). In contrast, the abundance of the Phyla Bacteroidetes (11.2 ± 5.2% vs. 26.3 ± 6.5%; P = 0.191), and Firmicutes (26.8 ± 7.6% vs. 24.9 ± 4.7%; P = 0.803), were not significantly different between those who were NV and not NV-infected. Of note, the diversity metrics of Shannon (3.5 ± 0.4 vs. 3.8 ± 0.3; P = 0.637) and inverse Simpson indices (1.3 ± 0.1 vs. 1.1±0.1; P = 0.419) were not significantly different between the two groups. CONCLUSION: Norovirus-infected transplant recipients had a significantly higher relative abundance of Enterobactericeae in their gut microbiota compared with transplant recipients without norovirus infection. Future studies are needed to explore if this association is mechanistically important for norovirus infection. [Image: see text] DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6810383/ http://dx.doi.org/10.1093/ofid/ofz360.2249 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Chong, Pearlie P
Chong, Pearlie P
Hussain, Sarah K
Poulides, Nicole
Coughlin, Laura
Koh, Andrew Y
2571. Norovirus Infection and Gut Microbiota in Transplant Recipients
title 2571. Norovirus Infection and Gut Microbiota in Transplant Recipients
title_full 2571. Norovirus Infection and Gut Microbiota in Transplant Recipients
title_fullStr 2571. Norovirus Infection and Gut Microbiota in Transplant Recipients
title_full_unstemmed 2571. Norovirus Infection and Gut Microbiota in Transplant Recipients
title_short 2571. Norovirus Infection and Gut Microbiota in Transplant Recipients
title_sort 2571. norovirus infection and gut microbiota in transplant recipients
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810383/
http://dx.doi.org/10.1093/ofid/ofz360.2249
work_keys_str_mv AT chongpearliep 2571norovirusinfectionandgutmicrobiotaintransplantrecipients
AT chongpearliep 2571norovirusinfectionandgutmicrobiotaintransplantrecipients
AT hussainsarahk 2571norovirusinfectionandgutmicrobiotaintransplantrecipients
AT poulidesnicole 2571norovirusinfectionandgutmicrobiotaintransplantrecipients
AT coughlinlaura 2571norovirusinfectionandgutmicrobiotaintransplantrecipients
AT kohandrewy 2571norovirusinfectionandgutmicrobiotaintransplantrecipients